Private Vaccination Prices in NW3 London: Travel, Routine &amp; Specialist

Antibiotics for Travellers' Diarrhoea

Adults 18+

Stand-by azithromycin
Consultation + private prescription

£35 all-inclusive

Antibiotics for Travellers' Diarrhoea: detail, schedule & eligibility

Antibiotics for Travellers' Diarrhoea: key facts
Fact	Detail
Price	£35 incl. consultation & Rx
Age	18+

Travellers' diarrhoea (TD) is the most common health problem affecting overseas travellers. Stand-by antibiotics such as azithromycin are strictly for those at higher risk of severe illness or visiting high-risk areas, supplied following a consultation.

Studies of probiotics to prevent TD are ongoing, but current evidence is insufficient to recommend their use.

Learn more via the CDC guidelines on Travellers' Diarrhoea.

Antimalarial Medication

Adults & children (from 5 kg)

4 drug options
Consultation + private prescription

from £0.50 per tablet 4 options

Antimalarial Medication: detail, schedule & eligibility

Important: the medications below are strictly for preventing malaria (prophylaxis), not treating it.

Antimalarial Medication: key facts
Fact	Detail
Atovaquone/Proguanil (adult)	£2.50/tab
Atovaquone/Proguanil (paed)	£1.75/tab
Doxycycline 100mg	£0.50/cap
Mefloquine 250mg	£4.80/tab

Atovaquone/Proguanil (adult or paediatric): 1 tablet daily, starting 1 to 2 days before travel, continue daily during stay, continue 7 days after return to a malaria-free area.

Doxycycline 100mg: 1 capsule daily, starting 1 to 2 days before travel, continue daily during stay, continue 4 weeks after return.

Mefloquine 250mg: 1 tablet weekly, starting 2 to 3 weeks before travel, continue weekly on the same day during stay, continue 4 weeks after return.

The right drug depends on your destination, medical history, and tolerability, and is chosen during your consultation. For more detail, see the TravelHealthPro factsheet on Malaria.

Chikungunya

12 years+

1 dose (Vimkunya®)
Non-live vaccine

£190 single dose

Chikungunya: detail, schedule & eligibility

Chikungunya: key facts
Fact	Detail
Price/dose	£190
Primary doses	1
Age	12+

Heard that a chikungunya vaccine was withdrawn? That was Ixchiq, a live vaccine. The MHRA announced on 20 October 2026 that its UK licence had been withdrawn after a safety review (Drug Safety Update). Vimkunya, the vaccine we use, is a different, non-live vaccine and is not affected by that decision. We have never used Ixchiq. If you had Ixchiq elsewhere, the MHRA advises that you do not need another vaccination; report any suspected side effect through the Yellow Card scheme.

Chikungunya is a mosquito-borne viral infection that's anything but minor. Around 3 in 4 people infected develop acute symptoms, typically severe joint pain, fever, and headache, and roughly 2 in 5 go on to experience debilitating joint pain that can last for months or even years. There is no specific cure: once infected, treatment is limited to managing symptoms.

For more detail, see the TravelHealthPro factsheet on Chikungunya.

Cholera

2 years+

Oral Dukoral
Boosters 2 yrs (6+) or 6 months (2 to 6 yrs)

£85 full course

Cholera: detail, schedule & eligibility

Cholera: key facts
Fact	Detail
Course	£85
Age	2+
Booster	2 yrs (6+) / 6 mo (2 to 6 yrs)

In addition to protection against cholera, the cholera vaccine Dukoral has shown efficacy against Enterotoxigenic Escherichia coli (ETEC), a common cause of travellers' diarrhoea, though note this is an off-label indication. Strict food and water hygiene remain essential alongside vaccination.

Learn more via the TravelHealthPro factsheet on Cholera.

Dengue Tetravalent (Qdenga)

4 years+

2 doses, 3 months apart (first dose before travel if time is short)
Usually for people who have had dengue before
Never had it? Assessed case by case

£119 per dose £238 course

Dengue Tetravalent (Qdenga): detail, schedule & eligibility

Dengue Tetravalent (Qdenga): key facts
Fact	Detail
Price/dose	£119
Primary doses	2 (3 mo apart)
Age	4+
Booster	None currently advised
Course total	£238 (2 doses)

Had dengue before? That is who Qdenga is usually recommended for in the UK (JCVI), because a second infection is the one most likely to be severe. Bring any results from that illness: a positive PCR or antigen test at the time is conclusive. If you were not tested, an antibody blood test can be arranged, though it is not definitive on its own (yellow fever, Japanese encephalitis and tick-borne encephalitis vaccines can affect the result), so we read it with your travel history. Growing up in, or living for years in, a dengue country also counts, since many infections cause no symptoms.

In trials, two doses given to people with a previous infection were 86% effective against hospitalisation with dengue and 65% effective against confirmed dengue illness (Green Book, chapter 15a).

Never had dengue? You can still be assessed. The Green Book (updated September 2026) says Qdenga is not usually recommended without a previous infection, but may be considered after discussion with a travel health clinician experienced in weighing its risks and benefits. That discussion is exactly what your consultation here provides. Mahyar Saremi is a Member of the Faculty of Travel Medicine of the Royal College of Physicians and Surgeons of Glasgow (MFTM RCPS(Glasg)), the college whose good practice guidance the Green Book cites at this point, and he routinely assesses travellers who have never had dengue.

What the evidence says: by July 2026 more than 32 million doses had been distributed worldwide, with no signal of severe dengue in people vaccinated without a previous infection. Data on two of the four serotypes (DENV-3 and DENV-4) are still limited, so JCVI keeps a precautionary position because of a theoretical risk of more severe illness if a vaccinated person who has never had dengue later meets one of those two. That is why this is an individual decision, not a routine offer.

Not suitable in pregnancy or when breastfeeding, for anyone with a weakened immune system (from a condition or its treatment), or under 4 years. Avoid pregnancy for at least a month after each dose.

Had dengue in the past year? UK guidance suggests waiting about a year after a laboratory-confirmed infection, because the infection itself gives short-lived protection against all four serotypes; the Green Book lists this as a precaution, not a contraindication. Our policy is never to vaccinate within six months of a dengue infection. Between six and twelve months, if you are travelling again, the timing is assessed case by case at your consultation.

Travelling in less than three months? The course is two doses three months apart, but you do not need both before you go: one dose can be given before travel and the second on your return. In the main trial, in 4 to 16 year olds living in dengue-endemic countries, protection began about 14 days after the first dose, and over the three months before the second dose one dose was 82% effective against confirmed dengue (Petri et al., Vaccine, 2024). The second dose completes the course, so we book it when we give the first. The same individual assessment applies whether or not you have had dengue, and bite avoidance matters whatever you decide.

Same-visit vaccines: Qdenga can be given at the same appointment as yellow fever, hepatitis A and non-live vaccines. There are no data yet on giving it with other live vaccines such as MMR, so we plan that spacing at your consultation.

Common side effects are a sore arm, headache, muscle aches, tiredness and fever, usually starting within two days, lasting one to three days and milder after the second dose. Full details are in the Qdenga Patient Information Leaflet (PDF).

For more detail, see the TravelHealthPro factsheet on Dengue and Dengue: the Green Book, chapter 15a.

Hepatitis A

1 year+

2 doses (now + 6 to 12 months)
Up to 25 years' protection after course

£65 per dose £130 course

Hepatitis A: detail, schedule & eligibility

Hepatitis A: key facts
Fact	Detail
Price/dose	£65
Primary doses	2
Age	1 year+
Booster	Up to 25 yrs
Course total	£130 (2 doses)

A liver infection caught from contaminated food and water. The standard schedule is two doses given 6 to 12 months apart; one dose gives protection from about two weeks after vaccination, which is usually enough for short trips.

Incomplete courses: if you had one dose years ago, you don't need to restart. A single second dose now will complete the course.

For more detail, see the TravelHealthPro factsheet on Hepatitis A.

Booking this for routine catch-up rather than travel? Book a Non-Travel Vaccination Appointment instead.

Hep A + Hep B Combined (Ambirix)

1 to 15 years

2 injections (0 + 6 to 12 months)
Combined Hep A + Hep B for children

£190 full course £95/dose

Hep A + Hep B Combined (Ambirix): detail, schedule & eligibility

Hep A + Hep B Combined (Ambirix): key facts
Fact	Detail
Full course	£190 (2 doses)
Price/dose	£95
Schedule	0 + 6 to 12 mo
Age	1 to 15 yrs

Did your child miss the NHS routine Hep B vaccination? Children born before 1 August 2017 missed the universal infant Hep B programme. The combined vaccine is an efficient way to catch up on both infections.

Why Ambirix? Two things set it apart. First, two injections rather than three, and five if hepatitis A and hepatitis B are given separately, so fewer needles and fewer appointments for a child. Second, it carries a full-strength hepatitis A component: 720 ELISA units, the same as a Havrix Junior Monodose. The three-dose combined paediatric alternative carries half that, at 360 ELISA units.

Which product suits the trip: protection against hepatitis B may not be reached until after the second dose, so Ambirix is used where the risk of hepatitis B infection during the vaccination course is relatively low. For higher-risk destinations or short-notice travel, the three-dose paediatric alternative on an accelerated schedule is the safer choice. We will advise at your consultation.

Delayed second dose: the second dose should ideally be 6 to 12 months after the first. Doses beyond this window fall outside the product licence, but evidence shows a delayed second dose still significantly boosts the immune response, and there is no maximum interval requiring a course restart.

Read the official guidance for Hepatitis A and Hepatitis B.

Catching up on routine immunisations rather than travelling? Book a Non-Travel Vaccination Appointment instead.

Japanese Encephalitis

2 months+

2 doses (standard 28 days or rapid 7 days)
Boosters 12 to 24 mo, then 10 yrs (adults 18 to 65)

£120 per dose £240 course

Japanese Encephalitis: detail, schedule & eligibility

Japanese Encephalitis: key facts
Fact	Detail
Price/dose	£120
Primary doses	2
Age	2 months+
1st booster	12 to 24 mo
Course total	£240 (2 doses)

Standard schedule: 0 and 28 days. Rapid schedule: 0 and 7 days, licensed for adults aged 18 to 65 (Green Book), ideal for travellers leaving in less than a month.

Unlicensed rapid-schedule use: According to the Green Book, for children (from 2 months) and adults aged 65+, the rapid schedule can be used when there is genuinely insufficient time to complete the standard schedule before travel. There are no data to suggest the rapid schedule would be harmful for these travellers.

For more detail, see the TravelHealthPro factsheet on Japanese Encephalitis.

Jet Lag (Melatonin)

Adults 18+

Adaflex 3 mg melatonin (30 tablets)
Consultation + private prescription

£49 all-inclusive

Jet Lag (Melatonin): detail, schedule & eligibility

Jet Lag (Melatonin): key facts
Fact	Detail
Price	£49 incl. consultation & Rx
Age	18+

We supply Adaflex 3 mg tablets (30 tablets), used for the short-term treatment of jet lag in adults. This is medical-grade melatonin.

For additional strategies on managing circadian rhythms, see the CDC Yellow Book: Jet Lag Disorder.

MenACWY (Meningitis ACWY)

6 weeks+

Required for Hajj/Umrah
Travel booster every 5 years
NHS schedule age 14 (catch-up to 25)

£70 per dose

MenACWY (Meningitis ACWY): detail, schedule & eligibility

MenACWY (Meningitis ACWY): key facts
Fact	Detail
Price/dose	£70
Age	6 weeks+
Travel booster	5 yrs

We offer MenACWY privately, with Nimenrix® from 6 weeks and MenQuadfi® from 12 months, well ahead of the NHS routine offer at age 14 (with catch-up available up to the 25th birthday).

Travel: MenACWY is required for Hajj and Umrah pilgrims entering Saudi Arabia (valid up to 5 years for conjugate vaccines), and recommended for long-stay or high-risk visitors to sub-Saharan Africa's meningitis belt, particularly in the dry season (December to June). Certification is included at no extra charge.

NHS vs travel guidance: JCVI doesn't routinely recommend NHS MenACWY boosters because the adolescent programme has driven UK cases to very low levels. That low domestic incidence doesn't apply to travellers. A self-pay booster is particularly relevant for travellers more than 5 years post-dose, unprimed adults (faster waning than primed adolescents), university students whose adolescent dose was at 13 to 14, and those with complement deficiency, asplenia, or complement-inhibitor use.

An early private dose does not replace the NHS vaccination at age 14, which should still be given at the appropriate time.

Booking for a routine schedule, university, or NHS catch-up, not travel? Book a Non-Travel Vaccination Appointment instead.

MMR (Measles, Mumps, Rubella)

6 months+ (travel/outbreaks)1 yr+ (routine)

2 doses, 4 weeks apart

£58 per dose £116 course

MMR (Measles, Mumps, Rubella): detail, schedule & eligibility

MMR (Measles, Mumps, Rubella): key facts
Fact	Detail
Price/dose	£58
Primary doses	2 (4 wks apart)
Age	6 mo (travel) / 1 yr+ (routine)
Course total	£116 (2 doses)

If you're travelling to an area where measles is common or currently circulating, please ensure you're fully up to date with the UK routine schedule before departure.

Early vaccination for babies: we can administer MMR from 6 months of age for babies travelling to a high-risk area or during a local outbreak. Treat this as a temporary extra dose for the trip. Your baby still needs the standard routine doses at 12 to 13 months and 18 months.

Vaccine spacing:

Yellow Fever & MMR: 4-week minimum interval. In urgent circumstances both may be given at any interval, with an additional MMR dose considered later (Green Book Ch.35).
Chickenpox & MMR: if not given the same day, 4-week minimum interval.
TB testing & MMR: MMR can be given on the same day as a TB blood test (IGRA) or a Mantoux, or at any time after an IGRA. Once a Mantoux has been given, delay MMR until it has been read, unless measles protection is needed urgently. After a recent MMR, wait four weeks before either test.

Booking this for routine catch-up rather than travel or outbreak? Book a Non-Travel Vaccination Appointment instead.

Rabies (Pre-Exposure)

All ages

Intradermal (ID) 1-week 4-dose regimen OR Intramuscular (IM) 0/7/21 days
Pre-exposure only

£60 per dose (ID) £240 course

Rabies (Pre-Exposure): detail, schedule & eligibility

Rabies (Pre-Exposure): key facts
Fact	Detail
ID injection	£60/dose
IM injection	£85/dose
Age	Birth+
Course total	£240 ID / £255 IM

Intradermal (ID), £60/dose: the 1-week, 4-dose regimen (MHRA-approved 2024, WHO-endorsed). Given as 4 doses over 2 appointments with a 7-day interval (1 dose in both arms per visit).

Intramuscular (IM), £85/dose: conventional schedule 0/7/21 days, or rapid schedule 0/3/7 days + 365-day booster.

Important: we do not provide rabies post-exposure treatment (after-bite care). If you need immediate care, please contact the UCLH Travel Clinic Services.

Booster guidance: after a complete primary pre-exposure course, most healthy travellers don't need routine boosters. UK guidance is to base any future doses on individual risk and, where relevant, antibody testing. People with continued high-risk exposure (lab staff, bat handlers) may need periodic serology and boosters via occupational health.

Tetanus, Diphtheria & Polio (Revaxis)

6 years+ and adults

Single booster dose
Tetanus, diphtheria and polio cover for travel, and the routine 10-yearly top-up

£42 single dose

Tetanus, Diphtheria & Polio (Revaxis): detail, schedule & eligibility

Tetanus, Diphtheria & Polio (Revaxis): key facts
Fact	Detail
Price	£42
Doses	1
Age	6 years+
Booster	Every 10 years

Revaxis is the standard adult booster covering tetanus, diphtheria and polio. One injection, and protection is generally maintained on a 10-yearly cycle once the childhood course is complete.

Commonly requested for: travel to areas where medical care is limited or wound treatment may be delayed, or where diphtheria or polio remain a risk; a lapsed 10-yearly booster; outdoor and agricultural work; and visa or occupational requirements.

Revaxis does not contain pertussis. If you need whooping cough protection, for pregnancy or around a newborn, you need Tdap instead.

Had a dirty or deep wound? Tetanus-prone injuries can need treatment as well as a booster, and sometimes tetanus immunoglobulin. Contact your GP, an urgent treatment centre or NHS 111 rather than booking a routine appointment with us.

For babies and children under 6, see the 5-in-1 or Tdap.

Booking a routine 10-yearly booster rather than for travel? Book a Non-Travel Vaccination Appointment instead.

Tick-borne Encephalitis (TBE)

1 year+

3-dose primary course
Rapid 14-day schedule available
Boosters every 3 to 5 yrs

£70 per dose £210 course

Tick-borne Encephalitis (TBE): detail, schedule & eligibility

Tick-borne Encephalitis (TBE): key facts
Fact	Detail
Price/dose	£70
Primary doses	3
Age	1 yr+
Course total	£210 (3 doses)

Short-notice travel: two doses on the rapid 14-day schedule provide over 90% protection for the current tick season. The third (completing) dose is still given 5 to 12 months after dose 2, even after your trip.

Schedules:

Standard: Dose 1 → Dose 2 at 1 to 3 months → Dose 3 at 5 to 12 months after Dose 2.
Rapid: Dose 1 → Dose 2 at 14 days → Dose 3 at 5 to 12 months after Dose 2. The minimum licensed interval from Dose 1 to Dose 2 is 14 days.

Incomplete or lapsed course? If you've had at least 2 prior TBE doses, you do not need to restart. A single catch-up dose will restore and extend your protection, regardless of how long it's been.

Boosters: first booster 3 years after Dose 3, then every 5 years (ages 1 to 59) or every 3 years (age 60+).

The top countries for TBE prevalence are Lithuania, Latvia, Estonia, Czech Republic, Slovenia, Sweden, and Austria. For more detail, see the TravelHealthPro factsheet on TBE.

Typhoid

2 yrs+ (injection) / 5 yrs+ (oral)

Single injection or 3 oral capsules
Booster every 3 yrs

£45 injection or oral course

Typhoid: detail, schedule & eligibility

Typhoid: key facts
Fact	Detail
Price/dose	£45
Age	2+ inj / 5+ oral
Booster	3 yrs

Oral capsules: a live vaccine given as 3 doses on alternate days (from 5 years).

Injection: a single-dose, non-live vaccine (from 2 years).

For children between 12 months and 2 years, off-label injection is possible following detailed risk assessment if the risk of typhoid fever is considered high. Immunisation is not recommended for children under 1 year. Scrupulous food and water hygiene by the caregiver is essential when children are too young to benefit from vaccination.

For more detail, see the TravelHealthPro factsheet on Typhoid.

Yellow Fever

9 months+

Single dose, lasting protection
YFVC required by law for many countries

£85 single dose

Yellow Fever: detail, schedule & eligibility

Yellow Fever: key facts
Fact	Detail
Price	£85/dose
Primary doses	1
Age	9 months+
Booster	None routine

A viral disease transmitted by mosquitoes, ranging from mild illness to severe disease. There's no specific treatment, so prevention is everything: strict bite avoidance plus vaccination if you're heading to a risk area.

Yellow fever vaccination is only available at designated UK Yellow Fever Vaccination Centres (YFVCs). We are NaTHNaC YFVC #5475, authorised to issue the International Certificate of Vaccination or Prophylaxis (ICVP) at no extra charge.

Age 60+: please review the NaTHNaC factsheet for suitability before your appointment, as the risk-benefit balance shifts with age.

Vaccine spacing: a four-week minimum interval between Yellow Fever and MMR. In urgent situations both may be given at any interval, with an additional MMR dose considered later (Green Book Ch.35).

For more detail, see the TravelHealthPro factsheet on Yellow Fever.

YF Certificate (Replacement / Exemption)

All ages

ICVP replacement (if record verifiable) OR medical-exemption letter

£30 flat fee

YF Certificate (Replacement / Exemption): detail, schedule & eligibility

YF Certificate (Replacement / Exemption): key facts
Fact	Detail
Price	£30
Age	All ages

Standard validity: existing ICVPs with 10-year validity are acceptable under International Health Regulations and do not routinely need reissuing.
Replacements: we can issue a replacement ICVP if your original is genuinely lost, badly damaged, or affected by a verified name change, provided an accurate medical record of the previous vaccination can be seen.
Lost records: if your certificate is lost and you don't have the official dates and batch numbers, the only legally-acceptable approach for immigration authorities is to repeat the vaccination.
Medical exemptions: we can issue medical letters of exemption from the ICVP when clinically appropriate.

For more detail, see the NaTHNaC factsheet on the ICVP or the YF vaccine recommendation maps.

Routine & Specialist Immunisations

Childhood, adolescent, and adult immunisations available privately, including catch-up doses, NHS-coverage-gap vaccines, and specialist offerings. Adults can walk in for a private flu or COVID-19 vaccination; all other private vaccinations are by appointment.

Book as: Non Travel Vaccination(s) - FIRST Appointment. Which appointment type do I need?

Vaccine or service

Age

Schedule and key facts

Price

Details

Book

5-in-1 (Infanrix-IPV+Hib)

8 weeks to 3 years

Diphtheria, tetanus, pertussis, polio and Hib in one injection
Routine infant course or private catch-up

£128 per dose

5-in-1 (Infanrix-IPV+Hib): detail, schedule & eligibility

5-in-1 (Infanrix-IPV+Hib): key facts
Fact	Detail
Price/dose	£128
Primary course	3 doses (£384)
Age	8 weeks to 3 years
Protects against	5 infections

Infanrix-IPV+Hib protects against diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus influenzae type b in a single injection. It is the private equivalent of the infant course, whether you are following the routine schedule privately or catching up after a missed or interrupted one.

Looking for the 6-in-1? The 6-in-1 vaccines (Infanrix hexa and Vaxelis) are supplied to the NHS only and cannot be bought privately. We achieve the same protection by giving the 5-in-1 alongside a separate hepatitis B vaccine, and the two are interchangeable with the NHS course.

Older children and adults need a different combination. From 3 years, see Tdap and whooping cough, and for the routine adult booster see tetanus, diphtheria and polio.

BCG (Tuberculosis) Vaccine

Birth onwards

Single dose, no booster
BCG AJV, the only BCG licensed in the UK

£105 single dose

BCG (Tuberculosis) Vaccine: detail, schedule & eligibility

BCG (Tuberculosis) Vaccine: key facts
Fact	Detail
Price	£105
Doses	1 (no booster)
Age	Birth+
Test first?	TB blood test from age 6

We administer BCG AJV, the only BCG vaccine licensed in the UK and the same one used by the NHS. It is a single intradermal dose that does not need a booster, given by a pharmacist who administers BCG routinely rather than occasionally.

A TB blood test (IGRA) is required first for anyone aged 6 and over. It is a separate appointment at £116, and the result takes about 3 working days, so please allow for both. Some children under 6 also need a test first: those who have lived for more than three months in a country with a high rate of TB, have had close contact with TB, or have a family history of TB in the last five years. If that applies, please email us before booking. See the TB blood test (IGRA).

Children born on or after 1 September 2021: please bring the Red Book and the newborn SCID screening result of 'not suspected' (a letter or a digital result) to the appointment.

Already vaccinated and need proof? We also offer a BCG scar check at £30, where the pharmacist examines and documents an existing BCG scar. This is usually requested for employment or university health clearance.

For more detail, visit our dedicated BCG and TB testing page.

Chickenpox (Varicella)

9 months+

2 doses, 4 to 8 weeks apart
2026 NHS MMRV policy affects who's eligible privately

£75 per dose £150 course

Chickenpox (Varicella): detail, schedule & eligibility

Chickenpox (Varicella): key facts
Fact	Detail
Price/dose	£75 (£150 course)
Primary doses	2 (4 to 8 wks apart)
Age	9 months+

Dose intervals: standard schedule is 2 doses 4 to 8 weeks apart. The absolute minimum licensed interval is 4 weeks.

NHS policy since January 2026: children now receive a combined MMRV vaccine on the NHS instead of MMR. Eligibility varies heavily by birthdate:

Children born on or before 31 Dec 2019 are not NHS-eligible, so they can only access varicella vaccination privately.
Children born 1 Jan 2020 to 31 Aug 2022 will be offered a single NHS MMRV catch-up dose (November 2026 to March 2028), provided they haven't had chickenpox or two varicella doses.

For more detail, see our dedicated Chickenpox vaccine page.

COVID-19 (Comirnaty XFG)

12 years+

Updated 2026/27 Pfizer Comirnaty XFG, 30 microgram dose
Private: adults can walk in or book online; ages 12 to 17 book online only
NHS-eligible? Book free via the NHS website or App, or walk in subject to availability (call first), not our online booking

£92 single dose

COVID-19 (Comirnaty XFG): detail, schedule & eligibility

COVID-19 (Comirnaty XFG): key facts
Fact	Detail
Price/dose	£92
Age	12 years+
Vaccine	Pfizer Comirnaty XFG, 30 micrograms
Private walk-in	Adults aged 18 and over, no appointment needed
Private booking online	From 12 years of age
NHS walk-in	Call first: subject to availability

We supply the updated 2026/27 Pfizer COVID-19 vaccine, Comirnaty XFG, which targets the XFG variant of the JN.1 lineage. We give the 30 microgram dose, for ages 12 and over, as a single injection whether or not you have had a COVID-19 vaccine before; if you have, it should be at least 3 months after your most recent dose. This is the private option for anyone outside the NHS autumn programme.

Private COVID-19 vaccine: walk in or book. Adults aged 18 and over can walk in without an appointment, or book online. Young people aged 12 to 17 are seen by appointment only: please book online.

Eligible for a free NHS COVID-19 vaccine? Please do not use our online booking for it: the booking system on this website is for private vaccinations only. Two free routes are available here:

Book through the NHS website or the NHS App and choose Hampstead Heath Pharmacy as your venue. Your dose is then reserved for you.
Walk in with no appointment, subject to the NHS stock we hold on the day. Please call us first on 020 7435 7075 to check, so you don't make a wasted trip.

NHS stock is supplied separately from our private vaccine, which is why walk-in doses depend on the day. Who we can vaccinate on the NHS here: from 1 October 2026 to 31 January 2027, adults aged 75 and over, and adults with a weakened immune system. Care home residents, housebound patients and under-18s are vaccinated through other NHS routes.

Not in an NHS group? Healthy adults under 75 are not (that includes frontline health and care workers), and that is who the private vaccine is for.

Full product details, including ingredients and possible side effects, are in the Comirnaty XFG Patient Information Leaflet (PDF).

Flu (Influenza)

6 months+ In stock now: confirmed 11/11/26 Subject to availability

Two 2026/27 vaccines, subject to availability: cell-based TIVc (egg-free) and adjuvanted aTIV (50+)
Private: adults can walk in or book online; under 18s book online only
NHS-eligible? Book free via the NHS website or App, or walk in (plenty in stock), not our online booking

£35 single dose

Flu (Influenza): detail, schedule & eligibility

Flu (Influenza): key facts
Fact	Detail
Price/dose	£35
Age	6 months+
Vaccine	Cell-based TIVc (6 months+) or adjuvanted aTIV (50+), 2026/27 season
In stock	Confirmed 11 Nov 2026, subject to availability
Private walk-in	Adults aged 18 and over, no appointment needed
Private booking online	From 6 months of age
NHS walk-in	No appointment or call needed

Two flu vaccines this season, subject to availability. Both are among the vaccines the UK flu programme recommends for 2026/27, both are made by Seqirus, and both carry the three strains recommended for the 2026/27 northern-hemisphere season. The cell-based trivalent vaccine (TIVc) is licensed from 6 months of age; it is grown in cell culture rather than in hens' eggs, so it is egg-free and the one we use for anyone with egg allergy. The adjuvanted trivalent vaccine (aTIV) is licensed for adults aged 50 and over; it is egg-based and contains the MF59 adjuvant, an ingredient added to boost the immune response. Which vaccine you receive depends on your age and on the stock held on the day; we tell you which you have had and record it. One dose for most people; children under 9 having flu vaccine for the first time need a second dose at least 4 weeks later, at the same £35.

Influenza has been described as the most frequent vaccine-preventable infection among travellers to tropical and subtropical countries.

Private flu vaccine: walk in or book. Adults aged 18 and over can walk in without an appointment, or book online. Children and young people aged 6 months to 17 years are seen by appointment only: please book online.

Eligible for a free NHS flu vaccine? Please do not use our online booking for it: the booking system on this website is for private vaccinations only. Two free routes are available here: book through the NHS website or the NHS App (NHS bookings opened on 17 August 2026), choosing Hampstead Heath Pharmacy as your venue, or simply walk in without an appointment. We have plenty of flu vaccine in stock, so there is no need to call ahead. Who we can vaccinate on the NHS here, and from when:

1 September 2026: pregnant women.
1 October 2026: adults aged 65 and over; adults aged 18 to 64 in a clinical risk group; carers and frontline health and social care workers; children aged 2 and 3 (born 1 September 2022 to 31 August 2024); and clinically at-risk children aged 4 to 17.
1 December 2026: school-aged children (Reception to Year 11) who missed their flu vaccination at school.

Everyone else who is eligible, including care home residents and housebound patients, is vaccinated through their GP or the school programme.

Not in an NHS group? Most healthy adults under 65 are not, and that is who the private vaccine is for.

Full product details, including ingredients and possible side effects, are in the Patient Information Leaflets: cell-based TIVc (PDF) and adjuvanted aTIV (PDF).

Hepatitis B

Birth onwards

3- or 4-dose course (standard or rapid)
Routine boosters not generally required

£55 per dose

Hepatitis B: detail, schedule & eligibility

Hepatitis B: key facts
Fact	Detail
Price/dose	£55
Primary doses	3 or 4
Age	Birth+
Course total	£165 (3 doses)

Schedules: Standard (0, 1, 6 months) or Rapid (0, 7, 21 days + 12-month booster) when time is short prior to travel.

Boosters: per the updated Green Book (Chapter 18), routine boosters are not currently recommended for travellers or healthcare workers with healthy immune systems who completed a primary course and responded, even after 5 years.

For more detail, see the TravelHealthPro factsheet on Hepatitis B.

Need Hepatitis B for a trip? Rapid courses fit most departure dates. Book a Travel Health Consultation instead.

HPV 9-Valent (Gardasil 9)

9 years+ (no upper limit)

2-dose schedule (now NHS-recommended for adults) or 3-dose standard schedule

£180 per dose

HPV 9-Valent (Gardasil 9): detail, schedule & eligibility

HPV 9-Valent (Gardasil 9): key facts
Fact	Detail
Price/dose	£180
Age	9+ (no upper limit)
Course total	£360 (2) / £540 (3)

2-dose schedule (NHS-recommended for adults): 0 and 6 months (minimum 6 months apart). This schedule provides highly effective protection and reflects current NHS / JCVI guidance for adults seeking HPV vaccination.

Standard 3-dose schedule: 0, 2, and 6 months.

Minimum interval Dose 1 & 2: 1 month
Minimum interval Dose 2 & 3: 3 months
All three doses must be given within a 1-year period.

For more detail, see our dedicated HPV vaccination page.

Mantoux Skin Test (TB)

Limited supply
By written approval only
One price covers the test and the reading

£116 per test

Mantoux Skin Test (TB): detail, schedule & eligibility

Mantoux Skin Test (TB): key facts
Fact	Detail
Price	£116
Reading	At 48 to 72 hrs, included
Availability	Limited, by approval
Alternative	TB blood test (IGRA)

Very limited supply. The solution used for the Mantoux test is out of stock with our supplier, and we do not expect new stock before 2027. We keep a small reserve for people with a written requirement for a Mantoux only. Please email us the requirement first, and book only once we have approved it.

The Mantoux test is the standard UK tuberculin skin test. A small amount of tuberculin is injected into the forearm, and the reaction is read 48 to 72 hours later. That reading window is fixed and cannot be moved, so we arrange it with you at the time of the test.

The reading is included. The £116 covers both the test and the reading. The reading can be done in person, or remotely from photographs of the site sent within the 48 to 72 hour window.

Need a TB test before BCG, or for work or study? We now use the TB blood test for both. See the TB blood test (IGRA).

For how to request a Mantoux, visit our BCG and TB testing page.

How to request a Mantoux

Request

MenB (Meningitis B)

2 months+ (Bexsero) / 10 years+ (Trumenba)

2 to 3 doses depending on age & brand
Catch-up for those born before 1 May 2015

£140 per dose

MenB (Meningitis B): detail, schedule & eligibility

MenB (Meningitis B): key facts
Fact	Detail
Price/dose	£140
Primary doses	2 to 3 (age-dependent)
Brands	Bexsero / Trumenba
Age	2 mo+ (Bexsero) / 10+ (Trumenba)
Course total	£280 (2 doses)

Check first: you may qualify for a free NHS MenB dose. A one-off NHS programme is running for people aged 17 to 18, anyone up to 24 starting university or further education for the first time in autumn 2026, and international students in England. Both free routes are available here: walk in to our pharmacy with no appointment, or book online with the NHS. Full eligibility details and NHS booking are on our pharmacy services page.

Age requirements & vaccination gap: individuals born before 1 May 2015 didn't receive MenB on the routine NHS programme. We stock both Bexsero (licensed from 2 months, the same vaccine used on the NHS routine infant schedule) and Trumenba (licensed for ages 10+). Schedules vary by brand and age, so we'll advise during consultation.

Boosters: JCVI doesn't currently recommend NHS MenB boosters, a decision driven primarily by population-level cost-effectiveness, not by evidence that boosters are clinically ineffective. Protective antibody levels decline in the years after a primary course, and late adolescence (especially the first year of university) is a second peak in meningococcal disease risk.

Key groups to consider for a booster:

University students: teenagers and young adults entering higher education or shared accommodation.
Occupational exposure: lab staff working with N. meningitidis (UK guidance: MenB boosters every 5 years).
Clinical risk factors: complement deficiency, asplenia, or similar conditions.

Boosters must use the same brand as the primary course. Optimal timing depends on when your primary course completed and your circumstances, generally considered after 5 years; we'll advise during consultation.

Pneumococcal (PCV13 / PCV20 / PCV21)

6 weeks+ (PCV13/20)

Capvaxive (PCV21): adults 18+, or ages 2 to 17 after the routine childhood schedule
Options based on age & prior doses
Free NHS walk-in dose if eligible

£109 to £156 per dose 3 options

Pneumococcal (PCV13 / PCV20 / PCV21): detail, schedule & eligibility

Pneumococcal (PCV13 / PCV20 / PCV21): key facts
Fact	Detail
Prevenar 13 (PCV13)	£109 (6 wks+)
Prevenar 20 (PCV20)	£117 (6 wks+)
Capvaxive (PCV21)	£156 (2 yrs+)

Free on the NHS here, as a walk-in. We give the NHS dose of Prevenar 20 (PCV20), no appointment needed, if you are aged 65 or over, or aged 18 to 64 with a long-term condition (chronic lung, heart, kidney or liver disease, diabetes treated with medication, a weakened immune system or no working spleen, a cochlear implant, or a cerebrospinal fluid leak; asthma does not usually count). For most people it is a one-off vaccination with no booster (a few higher-risk groups, such as people with no working spleen or with chronic kidney disease, may need further doses; we will advise). If you have already had a pneumococcal vaccine on the NHS, including Pneumovax 23 (PPV23), you are not eligible for another NHS dose here; the Capvaxive option below is the private alternative. We check your NHS record first.

Pneumococcal pneumonia is a potentially serious bacterial lung disease. We offer multiple vaccine options based on age and previous NHS immunisations.

NHS vs private protection: in the NHS, PCV20 (Prevenar 20) is replacing PPV23 (Pneumovax 23) as the routine vaccine for adults aged 65 and over and eligible at-risk groups, phased in as remaining PPV23 stocks are used up. Capvaxive (PCV21) is not currently in the UK national programme but is available from us, privately.

We offer Capvaxive, a 21-valent pneumococcal conjugate vaccine licensed by the MHRA. It is licensed for adults aged 18 and over and, following a 2026 licence extension, for children and adolescents aged 2 to 17 who have already completed the routine childhood pneumococcal vaccination schedule. It is given as a single injection.

Capvaxive was formulated with adult disease patterns in mind, and its 21 serotypes were chosen to cover the strains most responsible for serious pneumococcal infections such as pneumonia and meningitis. Several of those serotypes sit outside the infant pneumococcal vaccines, which is why a single dose can also broaden protection for eligible older children and adolescents who have finished their routine schedule.

Clinical studies have shown that Capvaxive produces comparable immune responses to other licensed pneumococcal conjugate vaccines for the serotypes they share, and stronger immune responses for the additional serotypes unique to Capvaxive.

Capvaxive covers a broader range of the pneumococcal serotypes currently causing invasive disease in adults aged 65 and over in England than the 20-valent alternative. According to published UK epidemiological data, Capvaxive serotypes account for approximately 82% of invasive pneumococcal disease cases in England, compared with approximately 64% for the 20-valent vaccine.

Already had a pneumococcal jab? You may still be eligible for Capvaxive. If you have previously received PPV23 (Pneumovax), you can receive Capvaxive at least 1 year later. If you have previously received PCV20, a minimum interval of 4 weeks is recommended before receiving Capvaxive. Our pharmacist will review your vaccination history during your appointment and advise whether Capvaxive is right for you.

For full Capvaxive product information, including ingredients and possible side effects, read the Capvaxive Patient Information Leaflet (PDF).

For more detail on immunisation timings, see the UKHSA complete routine immunisation schedule.

Rotavirus (Rotarix)

6 weeks+

Live oral vaccine
Part of NHS routine schedule for eligible infants

£105 per dose £210 course

Rotavirus (Rotarix): detail, schedule & eligibility

Rotavirus (Rotarix): key facts
Fact	Detail
Price/dose	£105
Age	6 weeks+
Course total	£210 (2 doses)

Rotarix is a live oral rotavirus vaccine given as part of the standard infant routine schedule. For details on childhood immunisations and timings, see the complete routine immunisation schedule.

Read our full adult RSV guide

RSV: Adults & Pregnancy (Abrysvo)

Adults 60+At-risk 18 to 59Pregnant from 28 weeks

NHS: 75+, care home residents, pregnancy, at-risk 65 to 74 (since 1 Sept 2026)

£240 single dose

RSV: Adults & Pregnancy (Abrysvo): detail, schedule & eligibility

RSV: Adults & Pregnancy (Abrysvo): key facts
Fact	Detail
Price	£240/dose
Doses	1
Duration	2 to 3 RSV seasons

NHS coverage gap: the NHS programme covers adults aged 75 and over (extended to all 80+ and to older-adult care home residents on 1 April 2026), pregnant women from 28 weeks, and, since 1 September 2026, 65 to 74 year olds with chronic respiratory disease or immunosuppression. Adults aged 60 to 74 outside those groups, and other at-risk adults aged 18 to 64, still have no free NHS option, and private vaccination fills that gap.

A single dose of Abrysvo, ideally given in late summer or early autumn before the winter RSV peak.

NHS-eligible? Book via your GP or the NHS website.

Read our full infant RSV guide: eligibility, safety, side effects and FAQs

RSV: Nirsevimab (Beyfortus) for Babies

Birth to 24 months

One injection of a ready-made antibody, not a vaccine
NHS covers babies born before 32 weeks and high-risk babies only
Given September to end of February

£780 single dose 2nd season: £1,560

RSV: Nirsevimab (Beyfortus) for Babies: detail, schedule & eligibility

RSV: Nirsevimab (Beyfortus) for Babies: key facts
Fact	Detail
First season	£780 (50 mg or 100 mg by weight)
Second season	£1,560 (2× 100 mg)
Age	Birth to 24 months
Protection	At least 5 to 6 months

NHS programme, restricted eligibility. The NHS gives a long-acting RSV antibody (nirsevimab or clesrovimab) only to babies born before 32 weeks, and to babies and young children with moderate or severe chronic lung disease of prematurity, a lung condition needing oxygen or long-term ventilation at the start of the season, haemodynamically significant congenital heart disease, or severe combined immunodeficiency (SCID), through their hospital team. If your baby qualifies, please ask that team: it is free.

Every other baby, including healthy full-term babies and babies born at 32 to 36 weeks, is outside that programme; the NHS protects them through the mother's RSV vaccine in pregnancy only. If your baby is outside the programme, our prescribing pharmacist can give nirsevimab privately after a short assessment: from birth once home from hospital, through their first RSV season, whether or not the mother had the pregnancy vaccine.

What it is: a single injection of a ready-made antibody, not a vaccine. Levels in the blood peak within about six days and protection lasts at least five to six months, a full RSV season. In the HARMONIE trial of 8,058 babies, one dose reduced hospital admissions for RSV chest infection by 83.2% through the season (SmPC section 5.1; Green Book RSV chapter, June 2026). It can be given at the same appointment as the routine baby vaccines.

Dose: 50 mg for babies under 5 kg, 100 mg from 5 kg, same price; we weigh your baby in clinic. A second-season dose (200 mg as two injections) is licensed only for children up to 24 months who remain vulnerable to severe RSV disease, most of whom are covered by the NHS.

When to book: September or early October, before RSV starts to circulate; babies born during the season (October to February) as soon as they are home from hospital. We offer it until the end of February.

Our stock. Our stock is the EU pack of Sanofi's Beyfortus (nirsevimab), the same medicine the NHS uses for its highest-risk babies, imported through an MHRA-licensed wholesaler and importer in compliance with the UK regulations for importing medicines. Our pharmacist talks you through the pack at your appointment. The price you book at is the price you pay.

Shingles (Shingrix)

18+ (eligibility varies by risk)

2 doses, 2 to 6 months apart
Non-live recombinant vaccine

£230 per dose £460 course

Shingles (Shingrix): detail, schedule & eligibility

Shingles (Shingrix): key facts
Fact	Detail
Course price	£460 (£230/dose)
Primary doses	2 (2 to 6 mo apart)
Age	18+ (risk-dependent)

Shingrix is a non-live, highly effective recombinant zoster vaccine. Your immune system declines naturally with age, raising the risk of shingles even when you feel perfectly well. About 1 in 3 people will get shingles in their lifetime, and the risk of long-lasting nerve pain (postherpetic neuralgia) rises sharply over 50.

For more detail, see our dedicated Shingles vaccine page.

Book a Blood Testing Appointment

TB Blood Test (IGRA)

Age 10+ in clinic

One visit
Report in about 3 working days
Book as a Blood Testing Appointment

£116 per test

TB Blood Test (IGRA): detail, schedule & eligibility

TB Blood Test (IGRA): key facts
Fact	Detail
Price	£116
Visits	1
Result	About 3 working days
Age	10+ in clinic

The IGRA (interferon gamma release assay) is a blood test that shows whether your immune system has met TB bacteria. We take the sample here, The Doctors Laboratory (TDL) analyses it as QuantiFERON-TB Gold, and your report is emailed in about 3 working days.

One visit, with no reading to come back for. The £116 covers the blood sample, the laboratory analysis and your report.

How to book: in the booking form choose Blood Testing Appointment, not Non Travel Vaccination. Pick a day from Tuesday to Saturday, and write "IGRA" in the Reason for visit box.

Booking a TB test before a BCG? Have the blood test first, then book the BCG once the result is negative. Allow about a week for both steps. See the BCG vaccine.

Children aged 6 to 9: the sample is taken at TDL's patient reception in Wimpole Street, at £116 plus a £65 TDL blood draw charge. Please email us to arrange it.

Commonly requested for: testing before BCG from age 6, NHS and university occupational health clearance, and pre-employment checks for healthcare and education roles.

For more detail, visit our dedicated BCG and TB testing page.

Tdap / Whooping Cough (Repevax or Adacel)

3 years+ (Repevax) or 4 years+ (Adacel)

Single dose
For pregnancy, families around a newborn, preschool boosters and visa requirements

£100 single dose

Tdap / Whooping Cough (Repevax or Adacel): detail, schedule & eligibility

Tdap / Whooping Cough (Repevax or Adacel): key facts
Fact	Detail
Price	£100
Doses	1
Repevax	3 yrs+, with polio
Adacel	4 yrs+, no polio

Both vaccines protect against whooping cough (pertussis), diphtheria and tetanus. The difference is polio:

Repevax (Tdap-IPV), 4-in-1: adds polio. Suitable from 3 years. This is the one to choose for the preschool booster, for most visa requirements, and where polio cover is also due.
Adacel (Tdap), 3-in-1: no polio component. Suitable from 4 years, and the right choice when polio protection is already up to date.

Both are £100, so the choice is clinical rather than financial. The pharmacist will confirm which one fits your history at the appointment.

Pregnancy: whooping cough vaccination in pregnancy passes antibodies to your baby, protecting them in the first weeks of life before their own vaccinations begin. It is offered from 16 weeks, and giving it by around 32 weeks allows the most antibody transfer. It can still be given later in pregnancy if you have missed that window.

Around a newborn: partners, grandparents and anyone else in close contact with a new baby often choose a dose to reduce the chance of passing whooping cough on.

If you need a tetanus booster without pertussis, the lower-cost option is Revaxis. For babies under 3 years, see the 5-in-1.